Testing effectiveness (Phase 2)Study completedNCT01507194
What this trial is testing
Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)
Who this might be right for
Postoperative Nausea and Vomiting
Accenture 131